Fig. 9From: Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylationKaplan–Meier survival curves for patients in the TCGA dataset, stratified by high and low expression (separated at the median) of SOX2 (left) and PROM1 (right). There is no significant difference in survivals based on these single gene expressionsBack to article page